Kiniksa Pharmaceuticals International, plc (KNSA)

NASDAQ: KNSA · Real-Time Price · USD

63.95

+2.84 (4.65%)

At close: Jul 17, 2026, 4:00 PM EDT

64.53

+0.58 (0.91%)

After-hours: Jul 17, 2026, 7:19 PM EDT

KNSA Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	754.05	677.56	423.24	270.26	220.18	38.54
Revenue Growth (YoY)	56.71%	60.09%	56.61%	22.75%	471.24%	-
Cost of Revenue	80.6	77.67	60.91	33.41	22.9	9.1
Gross Profit	673.44	599.89	362.33	236.85	197.29	29.44
Selling, General & Admin	213.89	196.27	168.01	129.43	97.95	85.95
Research & Development	105	96.85	111.62	76.1	65.49	99.3
Other Operating Expenses	261.33	229.55	128.31	56.52	24.07	0.84
Total Operating Expenses	580.23	522.67	407.95	262.05	187.51	186.08
Operating Income	93.22	77.22	-45.62	-25.2	9.77	-156.64
Total Non-Operating Income (Expense)	12.77	11.65	9.46	8.54	1.25	0.1
Pretax Income	105.98	88.87	-36.15	-16.65	11.03	-156.54
Provision for Income Taxes	-23.86	-29.86	-7.04	30.74	172.34	-1.39
Net Income	73.06	59.01	-43.19	14.08	183.36	-157.92
Net Income to Common	73.06	59.01	-43.19	14.08	183.36	-157.92
Net Income Growth	-	-	-	-92.32%	-	-
Shares Outstanding (Basic)	75	74	71	70	69	69
Shares Outstanding (Diluted)	80	79	71	72	70	69
Shares Change (YoY)	10.56%	10.58%	-0.69%	2.13%	2.69%	10.89%
EPS (Basic)	0.98	0.80	-0.60	0.20	2.64	-2.30
EPS (Diluted)	0.90	0.75	-0.60	0.20	2.60	-2.30
EPS Growth	-	-	-	-92.31%	-	-
Free Cash Flow	164.23	136.42	25.41	13.17	5.7	-126.71
Free Cash Flow Growth	20.39%	436.82%	92.94%	130.99%	-	-
Free Cash Flow Per Share	2.04	1.73	0.36	0.18	0.08	-1.85
Gross Margin	89.31%	88.54%	85.61%	87.64%	89.60%	76.39%
Operating Margin	12.36%	11.40%	-10.78%	-9.32%	4.44%	-406.38%
Profit Margin	9.69%	8.71%	-10.21%	5.21%	83.28%	-409.72%
FCF Margin	21.78%	20.13%	6.00%	4.87%	2.59%	-328.75%
EBITDA	94.89	78.78	-43.92	-22.86	12.18	-154.28
EBITDA Margin	12.58%	11.63%	-10.38%	-8.46%	5.53%	-400.27%
EBIT	93.22	77.22	-45.62	-25.2	9.77	-156.64
EBIT Margin	12.36%	11.40%	-10.78%	-9.32%	4.44%	-406.38%
Effective Tax Rate	-22.51%	-33.60%	19.48%	-184.58%	1563.01%	0.88%

SEC Filings: 10-K · 10-Q